Sort
30,917 grants matching “tumor microenvironment”
Combining immunotherapy with molecularly targeted radiation therapy
$663,343Lawrence Fong · University Of California, San Francisco · R01 · FY2023 · CA
Tregulatory cell-mediated suppression of tumor elimination by NK cells and CD4 T cells
$663,340David H Raulet · University Of California Berkeley · R01 · FY2025 · CA
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center
$663,338Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2022 · CA
Understanding IDH mutant gliomas
$663,335Jing Wu · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity
$662,979Dung T Le · Johns Hopkins University · P01 · FY2022 · CA
Designer extracellular vesicles for cancer therapy
$662,946Xiaowei Xu · University Of Pennsylvania · R01 · FY2024 · CA
Exploiting dynamic in vivo interactions of peptide amphiphiles with lipid-containing biomolecules to develop a universal drug delivery platform
$662,913Adem Yildirim · Oregon Health & Science University · R01 · FY2025 · EB
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
$662,909Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2017 · CA
Multiplexed drug testing of micro-dissected tumors using a microfluidic platform with integrated electrochemical aptasensors
$662,835Albert Folch · University Of Washington · R01 · FY2025 · CA
Structure-based inhibition of chemokine signaling in the inflamed pancreas
$662,744Brian F Volkman · Medical College Of Wisconsin · R01 · FY2023 · DK
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer
$662,729Robert H Vonderheide · University Of Pennsylvania · R01 · FY2018 · CA
Modulation of Therapeutic Response
$662,663James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Multiscale analysis of metabolic inflammation as a driver of breast cancer
$662,592Gerald V Denis · Boston University Medical Campus · U01 · FY2022 · CA
Imaging radiation-enhanced drug delivery for safer and more effective chemoradiotherapy
$662,516Miles A Miller · Massachusetts General Hospital · R01 · FY2025 · CA
Early Detection and Diagnosis of Lung Cancer with Endomicroscopy
$662,413Melissa J Suter · Massachusetts General Hospital · R01 · FY2021 · CA
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer
$662,338Cesar M Castro · Massachusetts General Hospital · R01 · FY2021 · CA
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
$662,308Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
$662,209Richard J Price · University Of Virginia · R01 · FY2022 · EB
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
$662,209Richard J Price · University Of Virginia · R01 · FY2023 · EB
The Impact of Tissue Sialylation on Macrophage Polarization and Function
$662,130Brian A Cobb · Case Western Reserve University · R01 · FY2020 · AI
Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes
$662,119Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Tumor-Selective Radiosensitization by Targeting Hypoxia in Rectal Cancer
$662,096Terence Marques Williams · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Neoadjuvant Immunotherapy Platform Study Reveals Mechanisms of Response in Hepatocellular Carcinoma (HCC)
$662,037Mark Yarchoan · Johns Hopkins University · R01 · FY2024 · CA
Cell density effects on therapeutic sensitivity
$662,027Jayne Stommel · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
T-CELL TRAFFICKING INTO THE COLD TUMOR IMMUNE MICROENVIRONMENT
$661,876Northwestern University · · FY2019 · Defense Health Agency